Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|December 17, 2014
Combat-related facial burns: analysis of strategic pitfallsBenjamin W Johnson, Andrew Q Madson, Sarah Bong-Thakur, et al.
Prenatal Diagnosis|March 12, 2022
Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choicesBethan Bowden, Sikha de Souza, Alice Puchades, et al.
Haematologica|June 17, 2021
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute studySimon Rule, Wolney Gois Barreto, Javier Briones, et al.
F1000Research|October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trialAndrew Davies, Sharon Barrans, Cathy Burton, et al.
British Journal of Haematology|August 24, 2017
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studiesSimon Rule, Martin Dreyling, Andre Goy, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|September 3, 2014
Birth prevalence and survival of exomphalos in england and wales: 2005 to 2011Anna Springett, Elizabeth S Draper, Judith Rankin, et al.
Blood Advances|June 21, 2021
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphomaConstantine S Tam, Stephen Opat, David Simpson, et al.
Birth Defects Research|February 16, 2024
Updated EUROCAT guidelines for classification of cases with congenital anomaliesJorieke E H Bergman, Annie Perraud, Ingeborg Barišić, et al.
Ejhaem|July 18, 2022
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trialElizabeth H Phillips, Catherine Burton, Amy A Kirkwood, et al.
BMJ Open Quality|December 18, 2018
Training: improving antenatal detection and outcomes of congenital heart diseaseOrhan Uzun, Julia Kennedy, Colin Davies, et al.
Pageof 20